Medicine by Design
Medicine by Design brings together more than 130 leading researchers at UofT and its affiliated hospitals at the convergence of science, engineering and medicine to advance regenerative medicine discoveries and dramatically improve health outcomes. Created in 2015 with an unprecedented $114-million investment from the federal government’s Canada First Research Excellence Fund (CFREF), Medicine by Design marks a new chapter in Toronto’s long history of global excellence in regenerative medicine, positioning Canada to continue to lead the field for decades to come.
Medicine by Design's 9th Annual Symposium: Driving translation with transformative science
This year’s symposium is themed “Driving translation with transformative science.” Invited speakers and Medicine by Design principal investigators will focus on telling strong translational stories, starting with leading edge science and enabling technologies through to commercialization and patient impact. Since 2016, Medicine by Design has married high risk, high reward research, with a strategy for […]
Medicine by Design symposium panel and announcement put a focus on intentional innovation through partnerships
Medicine by Design’s 8th annual symposium — themed “Intentional Innovation” — attracted more than 750 registrants and featured an announcement about a new strategic alliance between Medicine by Design and CCRM.
Medicine by Design, CCRM launch alliance to bolster Canada’s leading position in regenerative medicine
Medicine by Design and CCRM are launching a new strategic alliance that aims to unlock Toronto’s potential as a world-leading ecosystem for regenerative medicine.
U of T-anchored hospital network among leading life sciences research hubs, report finds
The University of Toronto and its partner hospitals are propelling the Toronto region as a leading global hub for life sciences research – but its success is at risk from underinvestment. That’s among the findings of a new report that examines the strengths and challenges within the Toronto Academic Health Science Network (TAHSN) – which comprises U of T […]
Canada’s opportunity in the future of genomics
One of U of T’s strengths lie in human genomics, which is supported by top-ranked faculty and researchers, anchored by a strong network of affiliated hospitals and medical research centers. Together, this network continues to advance frontiers of knowledge in critical areas of genomics including genetic susceptibility to disease, personalized medicine, machine learning for biomedical data, and more. Innovation hubs like the Emerging and Pandemic Infections Consortium (EPIC), Precision Medicine Initiative (PRiME), Medicine by Design, and the Structural Genomics Consortium are part of a network of high-impact interdisciplinary research centres that leverage areas of focus such as infectious disease, regenerative medicine, cell therapy, drug discovery, open science and more.
Students push the boundaries of research and innovation: Groundbreakers S2 Ep.4
In Ep. 4 of the Groundbreakers video series, host Ainka Jess goes behind the scenes with student researchers from the Robotics Institute and Medicine by Design strategic initiatives, as well as the Black Founders Network.
Some of their work is literally out of this world.
U of T partners with Moderna to advance research in RNA science and technology
U of T and Moderna, Inc. – known for its mRNA-based COVID-19 vaccine – plan to work together to develop new tools to prevent and treat infectious diseases. Leah Cowen, U of T’s vice-president, research and innovation, and strategic initiatives, said U of T is excited to work alongside Moderna to protect society from current and future health threats.
Inaugural DSI Catalyst Grants support transformative data science research
The Data Sciences Institute (DSI) at the University of Toronto is funding seventeen cross-disciplinary research teams focused on using the transformative nature of data sciences to solve complex and pressing problems. “The global and research challenges we face today are increasingly complex. The DSI Catalyst Grant projects bring together collaborative research teams focused on the […]
Medicine by Design’s Pivotal Experiment Fund invests $1 million in four research teams to bridge the “valley of death” funding gap
By Julie Crljen|August 9th, 2021|Categories: News|Tags: cardiac, Cindi Morshead, EVLP, liver disease, lung, organ transplantation, Pivotal Experiment Fund, Shaf Keshavjee, stroke, team projects, translation The four researchers leading teams that are sharing $1 million in funding through the Pivotal Experiment Fund. Left to right: Hai-Ling Margaret Cheng, associate professor at the Institute of Biomedical Engineering, University of Toronto; Dr. Shaf Keshavjee, surgeon-in-chief at UHN’s Sprott Department of Surgery and director […]
Medicine by Design-funded researchers develop cell injection technique that could help reverse vision loss
University Professor Molly Shoichet. (Photo by Neil Ta) Story from: https://mbd.utoronto.ca/news/medicine-by-design-funded-researchers-develop-cell-injection-technique-that-could-help-reverse-vision-loss/ By Tyler Irving|August 19th, 2020|Categories: News|Tags: cell therapy, cycle 2, Molly Shoichet, team projects, vision Through research partially funded by Medicine by Design, U of T Engineering researchers have developed a new method of injecting healthy cells into damaged eyes. The technique could point […]
Critical planning for regenerative medicine therapies needs to happen now to ensure smooth adoption into health system
Article from: https://mbd.utoronto.ca/news/critical-planning-for-regenerative-medicine-therapies-needs-to-happen-now-to-ensure-smooth-adoption-into-health-system-paper-urges/ Regenerative medicine holds the potential to revolutionize health care, but critical work needs to be done now to ensure these new therapies will be safe, effective, affordable, and widely available to patients who need them. That is one of the key conclusions of a paper published online today in Cell & Gene Therapy Insights that […]
Medicine by Design launches Translation Talks
Article from https://mbd.utoronto.ca/news By Ann Perry|June 16th, 2020|Categories: News|Tags: commercialization, events, Summer by Design, Translation Talks Translation Talks is a weekly webinar series for trainees that will cover key concepts in translation and commercialization of regenerative medicine. (Photo by Neil Ta) Translating research discoveries into new products, therapies or companies isn’t something most graduate programs […]